Therapeutic Targets Database
BIDD Pharmainformatics Databases
 
   
   

 

TTD Drug ID: DCL001018

Drug Information
NameTgAAC-94
CompanyTargeted Genetics Corporation
IndicationPsoriatic arthritis, Rheumatoid arthritis
[ICD9: 696.0, 710-719, 714   ICD10: L40.5, M00-M25, M05-M06, M07]
Phase I/II    [1]
Structure

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
InChI1S/C20H29N5O3/c1-22-18(15-19(26)23(2)20(22)27)21-9-6-10-24-11-13-
25(14-12-24)16-7-4-5-8-17(16)28-3/h4-5,7-8,15,21H,6,9-14H2,1-3H3
InChIKeyICMGLRUYEQNHPF-UHFFFAOYSA-N
Canonical SMILESCN1C(=CC(=O)N(C1=O)C)NCCCN2CCN(CC2)C3=CC=CC=C3OC    
PubChem Compound IDCID 5639.
SuperDrug ATC IDC02CA06
SuperDrug CAS ID034661751;
ClinicalTrials.govNCT00126724;
TargetTumor necrosis factor (TNF-alpha)Inhibitor[1]
Ref 1Emerging drugs for psoriasis. Expert Opin Emerg Drugs. 2009 Mar;14(1):145-63. To Reference



 

Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.


Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore


All rights reserved.

   
 
 
Computer-aided Drug Design
about BIDD |  databases |  software |  teaching |  research |  links

 

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543